AIMC Topic: Clinical Trials, Phase IV as Topic

Clear Filters Showing 1 to 2 of 2 articles

On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions.

Artificial intelligence in medicine Aug 11, 2019
OBJECTIVES: We develop a fuzzy evaluation model that provides managers at different responsibility levels in pharmaceutical laboratories with a rich picture of their innovation risk as well as that of competitors. This would help them take better str...
Humans Research Risk Assessment Fuzzy Logic Models, Statistical Clinical Trials, Phase II as Topic Probability Drug Industry Inventions Drug Approval Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase IV as Topic Decision Making, Organizational Strategic Planning
View on PubMed DOI

Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy.

Diabetes research and clinical practice Nov 9, 2016
AIMS: Evaluate efficacy and hypoglycaemia according to concomitant oral antidiabetes drug (OAD) in people with type 2 diabetes initiating insulin glargine 100U/mL (Gla-100) or neutral protamine Hagedorn (NPH) insulin once daily.
Humans Female Male Incidence Diabetes Mellitus, Type 2 Hypoglycemic Agents Treatment Outcome Randomized Controlled Trials as Topic Glycated Hemoglobin Insulin Glargine Hypoglycemia Administration, Oral Drug Therapy, Combination Weight Gain Clinical Trials, Phase III as Topic Clinical Trials, Phase IV as Topic Insulin, Isophane Sulfonylurea Compounds
View on PubMed DOI
Popular Topics
Recent Journals